Top Health Care companies in Asia by EBITDA

This ranking features the top 1,073 Health Care companies in Asia ranked by EBITDA, totaling a EBITDA of USD 132.55 B, for July 06, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

…

Frequently Asked Questions

Which Health Care company in Asia has the highest EBITDA ?

The Health Care company in Asia with the highest EBITDA is Pfizer Limited (NSE: PFIZER.NS) at USD 18.13 B.

Which Health Care company in Asia has the lowest EBITDA ?

The Health Care company in Asia with the lowest EBITDA is Beximco Pharmaceuticals Limited (LSE: BXP.L) at None.

What are the top 10 Health Care companies in Asia by EBITDA ?

The top 10 Health Care companies in Asia by EBITDA are Pfizer Limited, Takeda Pharmaceutical Company Limited, Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Limited, Sinopharm Group Co. Ltd., WuXi AppTec Co., Ltd., China Resources Pharmaceutical Group Limited, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Sun Pharmaceutical Industries Limited and SECOM Co., Ltd..

What are the bottom 10 Health Care companies in Asia by EBITDA ?

The bottom 10 Health Care companies in Asia by EBITDA are Beximco Pharmaceuticals Limited, GFL Limited, Basma Adeem Medical Co., Miral Dental Clinics Co., China Pharma Holdings, Inc., Chemomab Therapeutics Ltd., Shanghai Bio-heart Biological Technology Co., Ltd., Balsm Alofoq Medical Co., Al-Razi Medical Co. and I-Mab.